No profile data available.
Edwards Lifesciences Corporation (EW) is a healthcare company in the heart treatment equipment industry, based in Irvine, United States, with about 16,000 full-time employees.
It reported revenue of $6.07 billion for fiscal year 2025, and net income of $1.07 billion. United States was its largest region in fiscal year 2025, with 58% of revenue. Its market capitalization was $49.06 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Edwards Lifesciences reported $6.07 billion in revenue for fiscal year 2025.
United States: 58% of revenue by region in fiscal year 2025, followed by Europe (25%).
$49.06 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (heart treatment equipment) include Heartflow, Inc. (HTFL), LivaNova PLC (LIVN), Pulse Biosciences, Inc. (PLSE), iRhythm Technologies, Inc. (IRTC).